People who ate soybean oil daily for a month tended to have slightly lower levels of a key inflammation signal called IL-6, though the result wasn’t strong enough to be certain.
Scientific Claim
A 4-week intake of 30 g/day of soybean oil is associated with a trend toward reduced interleukin-6 (IL-6) levels (P = 0.09), suggesting a possible anti-inflammatory effect that may precede changes in downstream markers like CRP.
Original Statement
“However, interleukin-6 showed a trend toward reduction in the soybean oil group (P = 0.09).”
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
probability
Can suggest probability/likelihood
Assessment Explanation
The P-value of 0.09 is not statistically significant, so definitive language like 'reduces' is inappropriate. The study design supports causal inference, but the result is suggestive, not conclusive.
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Systematic Review & Meta-AnalysisLevel 1aWhether soybean oil or LA supplementation consistently lowers IL-6 across trials.
Whether soybean oil or LA supplementation consistently lowers IL-6 across trials.
What This Would Prove
Whether soybean oil or LA supplementation consistently lowers IL-6 across trials.
Ideal Study Design
A meta-analysis of 15+ RCTs measuring IL-6 before and after 4–12 weeks of 15–30g/day soybean oil or purified LA in overweight/obese adults, with standardized assays and adjustment for baseline IL-6.
Limitation: Cannot determine if effect is direct or mediated by other factors.
Randomized Controlled TrialLevel 1bIn EvidenceCausal reduction of IL-6 by 30g/day soybean oil in overweight adults.
Causal reduction of IL-6 by 30g/day soybean oil in overweight adults.
What This Would Prove
Causal reduction of IL-6 by 30g/day soybean oil in overweight adults.
Ideal Study Design
A double-blind RCT with 120 overweight adults randomized to 30g/day soybean oil vs. palm oil for 8 weeks, with IL-6 measured at baseline, 2, 4, and 8 weeks using high-sensitivity ELISA.
Limitation: Short duration may miss delayed effects; small sample size limits power.
Prospective Cohort StudyLevel 2bLong-term association between dietary LA and IL-6 levels in free-living adults.
Long-term association between dietary LA and IL-6 levels in free-living adults.
What This Would Prove
Long-term association between dietary LA and IL-6 levels in free-living adults.
Ideal Study Design
A 10-year cohort of 3,000 adults with annual dietary LA intake assessments and serum IL-6 measurements, adjusting for BMI, smoking, and physical activity.
Limitation: Cannot prove causation due to confounding.
Evidence from Studies
Supporting (1)
This study gave people 30 grams of soybean oil a day for 4 weeks and found that a key inflammation marker (IL-6) went down a little, even if not by a lot — which is exactly what the claim says.